PHARMACEUTICAL COMPOSITION COMPRISING METFORMIN AND LOBEGLITAZONE
「PHARMACEUTICAL COMPOSITION COMPRISING METFORMIN AND LOBEGLITAZONE」对应一条老挝专利公开记录，由 CHONG KUN DANG PHARMACEUTICAL CORP. 于 2016-08-24 提交申请，当前状态为等待形式审查。公开档案中可核验：申请号 P/581，DIP 编号 LAP581，主管局代码 LA，保护类型 Patent - PCT National Phase。时间线要点：公开/公告日 2026-01-16。国际分类 / IPC 标注为 A61K 31/155、A61K 31/426、A61K 31/506、A61K 47/38、A61K 9/28。发明人 / 设计人包括 CHO, Min Kwan、LIM, Jong Lae、PARK, Shin Jung、SHIN, Eun Ji、SHIN, Teak Hwan。代理机构 / 代理人记载为 CONCETTI-LAO CO., LTD。公开摘要提示：The present invention provides a pharmaceumtical composition comprising metformin or a pharmaceutic-ally acceptable salt thereof and lobegl…。
LaoBiz profiles the Laos patent “PHARMACEUTICAL COMPOSITION COMPRISING METFORMIN AND LOBEGLITAZONE” from open registry fields, filed by CHONG KUN DANG PHARMACEUTICAL CORP. on 2016-08-24; current status: Awaiting formal examination. Identifiers include application No. P/581; DIP id LAP581; protection kind Patent - PCT National Phase. Key dates: publication 2026-01-16. Classification: A61K 31/155、A61K 31/426、A61K 31/506、A61K 47/38、A61K 9/28. Inventor(s)/designer(s): CHO, Min Kwan, LIM, Jong Lae, PARK, Shin Jung, SHIN, Eun Ji, SHIN, Teak Hwan. Abstract hint: The present invention provides a pharmaceumtical composition comprising metformin or a pharmaceutic-ally acceptable salt thereof and lobegl…. This prose is informational only and does not constitute legal advice, ownership proof or an infringement opinion.
ໜ້ານີ້ສະຫຼຸບ ສິດທິບັດ «PHARMACEUTICAL COMPOSITION COMPRISING METFORMIN AND LOBEGLITAZONE» ຈາກຂໍ້ມູນຈົດທະບຽນເປີດ, ຍື່ນໂດຍ CHONG KUN DANG PHARMACEUTICAL CORP. ໃນວັນທີ 2016-08-24; ສະຖານະ ລໍຖ້າກວດຮູບແບບ. ຕົວລະບຸ: ເລກທີຄຳຮ້ອງ P/581; ລະຫັດ DIP LAP581; ປະເພດການປົກປ້ອງ Patent - PCT National Phase. ວັນທີສຳຄັນ: ວັນເຜີຍແຜ່ 2026-01-16. ປະເພດ/ຫ້ອງ: A61K 31/155、A61K 31/426、A61K 31/506、A61K 47/38、A61K 9/28. ນັກປະດິດ/ນັກອອກແບບ: CHO, Min Kwan, LIM, Jong Lae, PARK, Shin Jung, SHIN, Eun Ji, SHIN, Teak Hwan. ສະຫຼຸບ: The present invention provides a pharmaceumtical composition comprising metformin or a pharmaceutic-ally acceptable salt thereof and lobegl…. ຂໍ້ມູນເພື່ອອ້າງອີງເທົ່ານັ້ນ ບໍ່ແມ່ນຄຳແນະນຳທາງກົດໝາຍ ຫຼື ໃບຢັ້ງຢືນສິດ.
P/581
图样
基础信息
- 类型
- 专利
- 申请号
P/581- 状态
- 等待形式审查
- 申请人
- CHONG KUN DANG PHARMACEUTICAL CORP.
- 代理机构
- CONCETTI-LAO CO., LTD
- 申请日期
- 2016-08-24
- 公开/公告日
- 2026-01-16
- 国际分类
- A61K 31/155 · A61K 31/426 · A61K 31/506 · A61K 47/38 · A61K 9/28
- 商品 / 服务
- —
办理流程
根据当前状态动态标注-
提交申请
-
形式审查 进行中
-
实质审查
-
公开
-
授权
关联分析
LaoBiz 企业数据库联动类似专利推荐
摘要
The present invention provides a pharmaceumtical composition comprising metformin or a pharmaceutic-ally acceptable salt thereof and lobeglit-azone or a pharmaceutically acceptable salt thereof and a pharmaceutical formula-tion comprising the same. The parma-ceutical composition can exhibit a syner-gistic effeet on glycemic control and can block the poten potential of side effts and the pharmaceutical formulation can be provide in the form of a combination for-mulation that is able to be administered once a day to thus improve medication compliance.
The present invention provides a pharmaceumtical composition comprising metformin or a pharmaceutic-ally acceptable salt thereof and lobeglit-azone or a pharmaceutically acceptable salt thereof and a pharmaceutical formula-tion comprising the same. The parma-ceutical composition can exhibit a syner-gistic effeet on glycemic control and can block the poten potential of side effts and the pharmaceutical formulation can be provide in the form of a combination for-mulation that is able to be administered once a day to thus improve medication compliance.